HomeInsightsStock Comparison

Alembic Pharmaceuticals Ltd vs Colinz Laboratories Ltd Stock Comparison

Alembic Pharmaceuticals Ltd vs Colinz Laboratories Ltd Stock Comparison

Last Updated on: Jun 06, 2025

Key Highlights

  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 987.85 as of 06 Jun 15:30.
  • The P/E Ratio of Alembic Pharmaceuticals Ltd changed from 12.1 on March 2020 to 31.4 on March 2024 . This represents a CAGR of 21.01% over 5 yearsThe P/E Ratio of Colinz Laboratories Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10059 crore on March 2020 to ₹ 19309 crore on March 2024 . This represents a CAGR of 13.93% over 5 yearsThe Market Cap of Colinz Laboratories Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Alembic Pharmaceuticals Ltd for the Mar '25 is ₹ 1783 crore as compare to the Dec '24 revenue of ₹ 1702 crore. This represent the growth of 4.77% The revenue of Colinz Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Alembic Pharmaceuticals Ltd for the Mar '25 is ₹ 285.46 crore as compare to the Dec '24 ebitda of ₹ 270.08 crore. This represent the growth of 5.69% The ebitda of Colinz Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Alembic Pharmaceuticals Ltd changed from ₹ 120.6 crore to ₹ 156.63 crore over 8 quarters. This represents a CAGR of 13.96% The net profit of Colinz Laboratories Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Alembic Pharmaceuticals Ltd changed from 19.45 % on March 2020 to 32.44 % on March 2024 . This represents a CAGR of 10.77% over 5 yearsThe Dividend Payout of Colinz Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.
  • As per the scheme of arrangement, the 'Pharmaceutical Undertaking' of the Alembic Ltd was demerged and transferred to the company with effect from appointed date, April 1, 2010. In April 15, 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

About Colinz Laboratories Ltd

  • Colinz Laboratories Limited, was incorporated as a Private Limited Company in 1986.
  • The Company got converted into Public Limited Company in 1995, which however started their manufacturing and marketing activities in 1995.
  • The Company manufactures a wide variety of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams etc.
  • The Company is having certain specialized products for Gynaecology, Cardiology, Gastroentrology etc.
  • Since, the Company falls under the MSME sector, it established reputation as a quality supplier of medicines in the domestic market, wherever the Company has operation. Apart from this, the Company has a WHO compliant plant at Sinnar.

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharma slips as USFDA issues four observations for Panelav API facility

According to a regulatory filing, the USFDA conducted an unannounced and routine current g...

Read more

02 Jun 2025 11:58

News

Alembic Pharma receives USFDA final approval for Bosutinib tablets

Bosutinib tablets are indicated for the treatment of adult patients with chronic, accelera...

Read more

30 May 2025 15:42

News

Alembic Pharma receives USFDA nod for Amlodipine and Atorvastatin Tablets

Amlodipine and Atorvastatin tablets are a combination medication used to treat high blood ...

Read more

23 May 2025 15:08

News

Alembic Pharmaceuticals receives USFDA approval for Rivaroxaban Tablets

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from...

Read more

15 May 2025 14:14

News

Alembic Pharma rises on USFDA approval for Rivaroxaban Tablets

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

15 May 2025 16:36

News

Board of Alembic Pharmaceuticals recommends final dividend

Alembic Pharmaceuticals announced that the Board of Directors of the Company at its meetin...

Read more

06 May 2025 14:39

Colinz Laboratories Ltd News Hub

News

Colinz Laboratories to conduct board meeting

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 16 May...

Read more

08 May 2025 14:44

News

Colinz Laboratories to announce Quarterly Result

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 16 May...

Read more

08 May 2025 09:46

News

Colinz Laboratories to announce Quarterly Result

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 31 Jan...

Read more

14 Jan 2025 12:59

News

Colinz Laboratories to table results

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 30 Oct...

Read more

15 Oct 2024 10:07

News

Colinz Laboratories to hold AGM

Colinz Laboratories announced that the 38th Annual General Meeting (AGM) of the company wi...

Read more

16 Aug 2024 14:50

News

Colinz Laboratories announces board meeting date

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 8 Augu...

Read more

01 Aug 2024 19:37

SWOT Analysis Of Colinz Laboratories Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Colinz Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alembic Pharmaceuticals Ltd and Colinz Laboratories Ltd

Which company has a larger market capitalization, Alembic Pharmaceuticals Ltd or Colinz Laboratories Ltd?

Market cap of Alembic Pharmaceuticals Ltd is 19,417 Cr while Market cap of Colinz Laboratories Ltd is 28 Cr

What are the key factors driving the stock performance of Alembic Pharmaceuticals Ltd and Colinz Laboratories Ltd?

The stock performance of Alembic Pharmaceuticals Ltd and Colinz Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alembic Pharmaceuticals Ltd and Colinz Laboratories Ltd?

As of June 6, 2025, the Alembic Pharmaceuticals Ltd stock price is INR ₹987.85. On the other hand, Colinz Laboratories Ltd stock price is INR ₹61.33.

How do dividend payouts of Alembic Pharmaceuticals Ltd and Colinz Laboratories Ltd compare?

To compare the dividend payouts of Alembic Pharmaceuticals Ltd and Colinz Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions